The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of cadonilimab in combination with pulocimab and paclitaxel as second-line therapy in patients with advanced gastric or gastroesophageal junction (G/GEJ) cancer who failed immunochemotherapy: A multicenter, double-blind, randomized trial.
 
Xiaotian Zhang
No Relationships to Disclose
 
Yakun Wang
No Relationships to Disclose
 
Xiaojun Xiang
No Relationships to Disclose
 
Hongming Pan
No Relationships to Disclose
 
Jingdong Zhang
No Relationships to Disclose
 
Xiaobing Chen
No Relationships to Disclose
 
Yi Ba
No Relationships to Disclose
 
Ying Jieer
No Relationships to Disclose
 
Yifu He
No Relationships to Disclose
 
Xianli Yin
No Relationships to Disclose
 
Huiting Xu
No Relationships to Disclose
 
Li Xiao
No Relationships to Disclose
 
Lian Liu
No Relationships to Disclose
 
Juan Chen
No Relationships to Disclose
 
Jiachi Ma
No Relationships to Disclose
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)
 
Ting Liu
Employment - Akeso Biopharma
 
Wei Liu
Employment - Akeso Biopharma
Leadership - Akeso Biopharma
Stock and Other Ownership Interests - Akeso Biopharma
 
Baiyong Li
Employment - Akeso Biopharma
Leadership - Akeso Biopharma
Stock and Other Ownership Interests - Akeso Biopharma
 
Yu Xia
Employment - Akeso Biopharma
Leadership - Akeso Biopharma
Stock and Other Ownership Interests - Akeso Biopharma